MAXCYTE, INC. cotiza a 1.00 USD y tiene una capitalización bursátil de $103M. En los últimos 12 meses ha facturado $31M con un margen de flujo de caja libre del -109.5%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production…
| Periodo | 2026-11 | 2026-03 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | — | $-0.06 | $-0.09 | $-0.12 |
| Estimado | $-0.08 | $-0.08 | $-0.10 | $-0.10 |
| Sorpresa | — | +25.0% | +10.0% | -20.0% |
| Métrica | MXCT | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 81.2% | 57.0% | +24.1% |
| Operating Margin | -157.1% | -38.6% | -118.5% |
| Net Margin | -135.1% | -33.6% | -101.6% |
| FCF Margin | -109.5% | -13.9% | -95.7% |
| ROE | -26.0% | -40.4% | +14.4% |
| ROA | -22.0% | -32.0% | +10.0% |
| Current Ratio | 8.30 | 2.84 | +5.46 |
| Debt / Equity | — | 0.28 | — |